VMD Viemed Healthcare Inc
Price (delayed)
$7.45
Market cap
$289.25M
P/E Ratio
29.8
Dividend/share
N/A
EPS
$0.25
Enterprise value
$292.91M
Viemed Healthcare Inc. is a provider of in-home medical equipment and post-acute respiratory healthcare services in the United States. Viemed's service offerings are focused on effective in-home treatment with clinical
Highlights
The revenue has grown by 32% year-on-year and by 6% since the previous quarter
VMD's gross profit is up by 32% YoY and by 6% QoQ
Viemed Healthcare's EPS has increased by 32% YoY but it has decreased by 7% QoQ
The net income has increased by 29% year-on-year but it has declined by 8% since the previous quarter
The company's debt rose by 31% QoQ and by 21% YoY
The price to earnings (P/E) is 10% higher than the 5-year quarterly average of 27.6 and 2.7% higher than the last 4 quarters average of 29.6
Key stats
What are the main financial stats of VMD
Market
Valuations
Earnings
Shares outstanding
38.83M
Market cap
$289.25M
Enterprise value
$292.91M
Price to book (P/B)
2.42
Price to sales (P/S)
1.41
EV/EBIT
20.11
EV/EBITDA
7.5
EV/Sales
1.42
Revenue
$205.7M
EBIT
$14.57M
EBITDA
$39.06M
Free cash flow
$10.4M
Per share
Balance sheet
Liquidity
EPS
$0.25
Free cash flow per share
$0.27
Book value per share
$3.07
Revenue per share
$5.3
TBVPS
$3.35
Total assets
$163.95M
Total liabilities
$42.77M
Debt
$12.47M
Equity
$119.37M
Working capital
$13.5M
Debt to equity
0.1
Current ratio
1.43
Quick ratio
1.14
Net debt/EBITDA
0.09
Margins
Efficiency
Dividend
EBITDA margin
19%
Gross margin
60.9%
Net margin
4.6%
Operating margin
7.4%
Return on assets
6.1%
Return on equity
8.3%
Return on invested capital
15.5%
Return on capital employed
11%
Return on sales
7.1%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VMD stock price
How has the Viemed Healthcare stock price performed over time
Intraday
-1.97%
1 week
1.36%
1 month
0.13%
1 year
0.81%
YTD
-5.1%
QTD
13.74%
Financial performance
How have Viemed Healthcare's revenue and profit performed over time
Revenue
$205.7M
Gross profit
$125.37M
Operating income
$15.32M
Net income
$9.47M
Gross margin
60.9%
Net margin
4.6%
The operating income has soared by 56% YoY and by 4.9% from the previous quarter
The revenue has grown by 32% year-on-year and by 6% since the previous quarter
VMD's gross profit is up by 32% YoY and by 6% QoQ
The net income has increased by 29% year-on-year but it has declined by 8% since the previous quarter
Growth
What is Viemed Healthcare's growth rate over time
Valuation
What is Viemed Healthcare stock price valuation
P/E
29.8
P/B
2.42
P/S
1.41
EV/EBIT
20.11
EV/EBITDA
7.5
EV/Sales
1.42
Viemed Healthcare's EPS has increased by 32% YoY but it has decreased by 7% QoQ
The price to earnings (P/E) is 10% higher than the 5-year quarterly average of 27.6 and 2.7% higher than the last 4 quarters average of 29.6
The P/B is 23% lower than the 5-year quarterly average of 3.2 and 5% lower than the last 4 quarters average of 2.6
The equity is up by 4.8% year-on-year and by 2.7% since the previous quarter
The P/S is 35% below the 5-year quarterly average of 2.2 and 11% below the last 4 quarters average of 1.6
The revenue has grown by 32% year-on-year and by 6% since the previous quarter
Efficiency
How efficient is Viemed Healthcare business performance
The company's return on invested capital rose by 31% YoY but it fell by 7% QoQ
The ROE has grown by 19% YoY but it has contracted by 9% from the previous quarter
The ROA is up by 13% YoY but it is down by 9% QoQ
Viemed Healthcare's return on sales has increased by 9% YoY but it has decreased by 9% QoQ
Dividends
What is VMD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VMD.
Financial health
How did Viemed Healthcare financials performed over time
VMD's current ratio is up by 20% YoY and by 12% from the previous quarter
VMD's quick ratio is up by 18% year-on-year and by 8% since the previous quarter
The company's debt is 90% lower than its equity
The company's debt rose by 31% QoQ and by 21% YoY
Viemed Healthcare's debt to equity has increased by 25% QoQ and by 11% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.